The expression of hepatocycte growth factor and its receptor in brain astrocytomas

National Medical Journal of China

Volumn 85, Issue 12, 2005, Pages 835-838

  Chu, Sheng Hua ^a   Yuan, Xian Hou ^a   Jiang, Pu Cha ^a   Li, Zhi Qiang ^a   Zhang, Jie ^a   Wen, Zhi Hua ^a   Zhao, Shi Yu ^a   Chen, Xin Jun ^a   Cao, Chang Jun ^a  

^a ZHONGNAN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

Astrocytoma; Hepatocyte growth factor; Neovascularization, pathologic; Receptors, growth factor

Indexed keywords

CD34 ANTIGEN; CYCLINE; MESSENGER RNA; MONOCLONAL ANTIBODY; SCATTER FACTOR; SCATTER FACTOR RECEPTOR; GROWTH FACTOR RECEPTOR; MET PROTEIN, HUMAN; ONCOPROTEIN; TUMOR MARKER;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; ASTROCYTOMA; CANCER GRADING; CANCER LOCALIZATION; CANCER SURVIVAL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; MALE; MICROVASCULATURE; NEUROSURGERY; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; SURVIVAL TIME; TUMOR VASCULARIZATION; TUMOR VOLUME; BIOSYNTHESIS; BRAIN TUMOR; GENETICS; METABOLISM; MIDDLE AGED; NEOVASCULARIZATION (PATHOLOGY);

ADULT; AGED; ASTROCYTOMA; BRAIN NEOPLASMS; FEMALE; HEPATOCYTE GROWTH FACTOR; HUMANS; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PROTO-ONCOGENE PROTEINS; RECEPTORS, GROWTH FACTOR; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 16844385694     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Di renzo MF, Poulsom R, Olivero M, et al. The prognostic significance of amplification and overexpression of c-met and c-erb B-2 in human gastric carcinomas. Cancer, 1999, 85: 1894-1902.
2. Cai YG, Fang DC, Yang SM, et al. Increased expression of heparanase mRNA is correlated with metastasis of gastric carcinoma and is probably correlated with c-met protein. Natl Med J China, 2004, 84:974-978.
3. Kermorgant S, Aparicio T, Dessirier V, et al. Hepatocyte growth factor induces colonic cancer cell invasiveness via enhanced motility and protease overproduction evidence for PI3 linase and pkc involvement. Carcinogenesis,2001,22:1035-1042.
4. Furge KA, Zhang YW, Vande Woude GF, et al. Met receptor tyrosine kinase: enhanced signaling through adapter proteins. Oncogene, 2000, 19:5582-5589.
5. Cai BW, Wu B, You C. The expression and significance of c-Met, receptor of SF/HGF, in human astrocytoma. Sichuan Med J, 2004, 25:838-839.
6. Takuzou M, Hiroaki K, Hirokazu K, et al. Comparative analysis of expression of hepatocyte growth factor and its receptor, c-met, in gliomas, meningiomas and schwannomas in humans. Cancer Lett, 1998, 124:149-155.
7. Gautam M, Amol S, Takashi K, et al. Role of the hepatocyte growth factor receptor, c-Met, in oncogenesis and potential for therapeutic inhibition. Cytokine Growth Factor Rev, 2002, 13: 41-59.
8. Parr C, Davies G, Nakamura T, et al. The HGF/SF-induced phosphorylation of paxillin, matrix adhesion, and invasion of prostate cancer cells were suppressed by NK4, an HGF/SF variant. Biochem Biophys Res Commun,2001, 285:1330-1337.